Position in ABBV
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$8,268,268,167
-$880,914,691 QoQ
Shares Held
38,016,774
-5.1% QoQ
Ownership
2.15%
of shares outstanding
% of Portfolio
0.66%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 44.07430520012034.ToString("F0")%
Shared 0.ToString("F0")%
None 55.92569479987966.ToString("F0")%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $57,054,147,722 across 20 Drug Manufacturers - General names. ABBV ranks #3 (14.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
15,437,458 | $14,198,910,733 | |
| 2 | JNJ |
Johnson & Johnson
|
44,721,167 | $10,931,642,052 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
38,016,774 | $8,268,268,167 | |
| 4 | MRK |
Merck & Co., Inc.
|
47,632,487 | $5,729,711,852 | |
| 5 | AMGN |
Amgen Inc
|
15,836,058 | $5,571,916,998 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
23,299,295 | $3,247,222,731 | |
| 7 | PFE |
Pfizer Inc
|
92,685,370 | $2,602,605,180 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
29,198,554 | $1,770,892,290 |
All Filings in ABBV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,268,268,167 | 38,016,774 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $9,149,182,858 | 40,041,940 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $9,644,748,676 | 41,654,784 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $7,740,354,174 | 41,700,001 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $8,621,692,258 | 41,149,734 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $7,052,764,430 | 39,689,164 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $7,645,803,726 | 38,716,851 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $6,388,035,639 | 37,243,678 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $6,404,764,558 | 35,171,689 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $5,277,121,340 | 34,052,535 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $4,796,084,045 | 32,175,527 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $4,211,800,181 | 31,261,042 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $5,008,679,393 | 31,427,994 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $5,102,310,507 | 31,571,750 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $3,595,012,534 | 26,786,473 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,993,728,782 | 26,075,534 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $3,060,917,246 | 18,881,730 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $2,622,831,772 | 19,370,988 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,048,056,706 | 18,986,342 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $2,133,929,537 | 18,944,687 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $2,026,988,948 | 18,730,262 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,750,456,506 | 16,336,505 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $1,202,738,140 | 13,731,455 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $1,220,846,894 | 12,434,782 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $819,530,873 | 10,756,410 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||